http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
급성 골수성 백혈병 10세 환아의 한방적 처치에 대한 증례보고
하광수,송인선,신지나,이정림,Ha, Kwang-Su,Song, In-Sun,Shin, Ji-Na,Lee, Jeong-Lim 대한한방소아과학회 2004 대한한방소아과학회지 Vol.18 No.2
저자는 급성 골수성 백혈병으로 진단받은 환아의 범혈구감소증으로 인한 출혈(出血)소견과 전신자반증(全身紫班症), 정신의식계통의 혼돈(混沌)과 극도의 허손(虛損)상태를 경험하고 이를 한방적으로 접근하여 짧은 기간이었으나마 호전도를 경험하였기에 보고하는 바이다. 백혈병은 아직까지는 한방으로 완치(完治)라는 것이 어려운 분야이지만, 일차적으로 관해 유도법을 도입하기전이나 관해 후의 허손(虛損)으로 환자의 체력이 됫받침되지 못할때 충분히 양방과 협진하여 그 효과를 입증할수 있다고 생각된다. 아직까지 한방분야에서 백혈병 등의 혈액암에 있어서는 그 문헌적인 연구는 미흡하나마 존재하지만, 임상적인 연구나 치료방법적인 면으로는 보고된 바가 부족하며 이 논문을 계기로 다양한 임상연구가 진행되었으면 하는 바람이다. Objective : The purpose of this study is to demonstrate the therapeutic effect of oriental treatment on Acute Myelogenous Leukemia. Methods : The patient was treated by Acupuncture, Indirect Moxibustion, Herb Medicine (Seogakjihwangtang-gamibang), and had significant improvement in the Acute Myelogenous Leukemia. Results : 1. Acute Leukemia is one of the most common malignant neoplasm of pediatrics, and is chracterised by anemia, infections, bleeding, debility, paleness, fever, anorexia, lymphoadenia, hepatomegaly, splenomegaly, etc. 2. The management of Acute Myelogenous Leukemia consists of the challenge of optimizing chance for prolonged remission and cure, while minimizing the toxicity to the patients. Therefore oriental medical treatment may be useful for this. 3. We experienced a case of the 10-year-old male patient with Acute Myelogenous Leukemia, after oriental medical treatment his chief symptoms(anemia, bleeding, purpura, debility, paleness, fever, anorexia, insomnia, etc)and general condition were improved. Conclusion : A 10-year-old male patient with Acute Myelogenous Leukemia, after oriental medical treatment his chief symptoms and general condition were improved. This oriental medical treatment may be possible or effective in Acute Myelogenous Leukemia. The more clinical study about oriental medical treatment on Acute Myelogenous Leukemia will be needed.
김굉식,이건주,김철수,이영구,강영석 인제대학교 1982 仁濟醫學 Vol.3 No.4
혈액형의 후천적 변화는 백혈병을 포함한 여러 질환에서 보고가 있었다. 저자들은 급성 골수성 백혈병 환자 일례에서 일신적인 A항원의 소실을 경험하였기에 문헌 고찰과 함께 보고하는 바이다. A 28 years old woman with acute myelogenous leukemia received many units of blood during remission induction period, and her blood was typed as group "O". However, when her leukemia went into remission, her blood group was turned out to be "A". This case illustrates temporary loss of red cell blood group "A" antigen in acute myelogenous leukemia.
급성 골수성 백혈병과 동반된 급성 발열성 호중구성 피부병 1예
오창남,강인경,최규철 조선대학교 1993 The Medical Journal of Chosun University Vol.18 No.2
Acute febrile neutrophilic dermatosis (Sweet's syndrome) is characterized by painful erythematous plaques, fever, leukocytosis and a dense dermal infiltrate of neutrophils at the site of skin lesion. We presented a case of acute febrile neutrophilic dermatosis in acute myelogenous leukemia in 24-year-old male. Painful and brownish noduloplaques appeared on the face after chemotherapy for acute myelogenous leukemia. Microscopic examination of biopsy specimen disclosed a dense dermal infiltrate composed mainly of neutrophils. Also there were many nuclear dust, but no evidence of true vasculitis.
Tetrasomy 8 in a Patient with Acute Monoblastic Leukemia
김주원,박태성,송재우,이경아,이상국,정준원,최종락 대한진단검사의학회 2008 Annals of Laboratory Medicine Vol.28 No.4
Trisomy 8 is one of the most frequent numerical chromosomal abnormalities observed in hematological malignancies, whereas tetrasomy 8 is a clonal aberration seen mainly in myeloid disorders such as acute myelod leukemia (AML) and myelodysplastic syndromes. In contrast to trisomy 8, tetrasomy 8 is a rare chromosomal aberration, in that only 17 reported AML cases with isolated tetrasomy 8 have been documented. Interestingly, the majority of reported cases were associated with monocytic-lineage leukemias. According to recent reports, tetrasomy 8 is regarded as a poor prognostic factor, and most patients having this abnormality relapsed and died within 1 yr. Here, we report a patient with acute monoblastic leukemia having tetrasomy 8 and a very aggressive disease course. (Korean J Lab Med 2008;28:262-6) Trisomy 8 is one of the most frequent numerical chromosomal abnormalities observed in hematological malignancies, whereas tetrasomy 8 is a clonal aberration seen mainly in myeloid disorders such as acute myelod leukemia (AML) and myelodysplastic syndromes. In contrast to trisomy 8, tetrasomy 8 is a rare chromosomal aberration, in that only 17 reported AML cases with isolated tetrasomy 8 have been documented. Interestingly, the majority of reported cases were associated with monocytic-lineage leukemias. According to recent reports, tetrasomy 8 is regarded as a poor prognostic factor, and most patients having this abnormality relapsed and died within 1 yr. Here, we report a patient with acute monoblastic leukemia having tetrasomy 8 and a very aggressive disease course. (Korean J Lab Med 2008;28:262-6)
정재근(Jae Gun Jung),서대규(Dae Gyu Seo),신왕식(Wang Sik Shin),한길성(Gil Sung Han),황기석(Kee Suk Whang) 대한내과학회 1995 대한내과학회지 Vol.49 No.6
The authors report the two cases about spontaneous remission of acute myelogenous leukemia developed after severe infection with brief review of leterature. The one case was that of a 31-year-old female admitted with acute myelogenous leukemia and orbital cellulitis, and the other case was that of a 25-year-old female admitted with acute myelogenous leukemia and pneumonia. In those two cases, we delayed chemotherapy because of severe infection. After that, we nuexpectedly could observe the spontaneous remission of acute leukemia. The two patients respectively had a short duration of remission for 6 weeks and 5 months.
단기간의 저용량 Cytosine arabinoside 치료에 반응하였던 Down 증후군에 병발한 급성골수성백혈병 1례
김현수,이정호,이정찬,강정현,곽상혁,김철희,배광봉,김종숙,조덕연,김삼용 충남대학교 의과대학 지역사회의학연구소 1998 충남의대잡지 Vol.25 No.1
The incidence of hematologic disorders in patients with Down's syndrome is significantly increased, about 14∼30 - fold higher than in general population and includes neonatal transient abnormal myelopoieis and acute leukemias. The age of onset of leukemia in Down's syndrome is peaking first in the newborn period and then under 4 years of age. Down's syndrome with acute leukemia above the age of 20 is very rare and it's treatment oucome is unclear. The treatment of Down's syndrome with leukemia has been controversial because of toxicity and associated congenital cardiac and other abnormalities. But if treated adequately, children with Down's syndrome show a favorable response to anti-leukemia therapy. A 24-year-old man with Down's syndrome was first seen for the evaluation of anemia and thrombocytopenia. The peripheral blood morphology and bone marrow study revealed acute myelogenous leukemia, cytogenetic study of bone marrow showed trisomy 21. Beacuse of his sicioeconomic condition and medical abnormalities including deafness, visual loss, he was treated with low dose subcutaneous cytosine arabinoside(Ara-C) for 11 days. Complete remission was obtained after 37 days. The complete remission lasted for 5 months. He subsequently relapsed, and died 6 months later.